Blog

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Blog

Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML

Photo from faculty.mdanderson.org

Jun 26, 2023, 18:40

Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML

In a post by Jared K. Burks on Linkedin, it says, “This is a double celebration as not only did I get to contribute to this wonderful article, but the first author, Russell Pourebrahim was just promoted to Assistant Professor. Congrats Rasoul on both the article and the promotion, very happy for you.
Mesenchymal stromal cells (MSCs) are a key component of the bone marrow (BM) niche, providing essential support required for the maintenance of hematopoietic stem cells. To advance our understanding of physiological functions of p53 and Mdm2 in BM-MSCs, we developed traceable conditional mouse models targeting Mdm2 and/or Trp53 in vivo. Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML and expand our understanding of the mechanism of hematopoietic toxicity of MDM2is.”

For Article : Click here

Source:

bone marrow cancer cancer care hematopoietic Jared K. Burks Mesenchymal stromal cells Oncology Research Russell Pourebrahim

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

'

Miranda McKeon: Battling Breast Cancer at 19, Inspiring Millions on Instagram

'

WHO Takes a Creative Leap in Raising Awareness for Colorectal Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Insight

Mar 29, 2025, 06:01

Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients

Blog

Mar 29, 2025, 04:55

Akhil Santhosh: Final overall survival results of checkmate 067 in NEJM

Blog

Mar 29, 2025, 04:16

Maximilian Merz: From student to academic physician - A 14-Year Journey at MSKCC

OncoDaily Pulse

Mar 29, 2025, 03:34

OncoDaily partners with EYOC aiming for innovation, research and equitable care

Career

Mar 29, 2025, 03:20

Nasim Eftekhari: I've been promoted to Chief AI and Analytics Officer at City of Hope

Insight

Mar 28, 2025, 20:51

Samer Al Hadidi: Check out our recent work in Blood Advances, led by Bhavesh Mohan Lal at the UAMS Myeloma Center

Blog

Mar 28, 2025, 20:17

Mustafa H. Alsaadi: Excited to share that three of our abstracts have been accepted for poster presentation at ASCO 2025

Blog

Mar 28, 2025, 20:11

Raffaele Giusti: MARIPOSA overall survival data at ELCC25

Blog

Mar 28, 2025, 19:58

Nina Niu Sanford: Here is HCC 101 video

Blog

Mar 28, 2025, 19:38

Julien Mazieres: Another brick in the wall of HER2-mutant NSCLC

Blog

Mar 28, 2025, 19:18

Liz Main Morrison: Not long until MPs vote on the Tobacco and Vapes Bill that will mean kids like Henry can never legally smoke

Blog

Mar 28, 2025, 18:51

Mukhtar Malcolm Alkali: I had the honor of representing Medicaid CF Programs at the grand launch of BRANT Program